Agilent Reports Strong Q2 2026 Growth Across Key Segments
Event summary
- Agilent reported $1.83 billion in revenue for Q2 2026, up 10% year-over-year and 6.3% core growth.
- GAAP net income rose to $339 million ($1.20 per share) from $215 million ($0.75 per share) in Q2 2025.
- Life Sciences and Diagnostics Markets Group (LDG) saw 12% revenue growth, while Applied Markets Group (AMG) grew 14%.
- Agilent CrossLab Group (ACG) reported 6% revenue growth with a 32% operating margin.
- CEO Padraig McDonnell highlighted the success of the Ignite Operating System and new product launches.
The big picture
Agilent's Q2 2026 results reflect broad-based strength across its diversified portfolio, particularly in life sciences and diagnostics. The company's focus on innovation and operational efficiency, supported by the Ignite Operating System, positions it well in a competitive market. The introduction of new solutions like the 9500 ICP-MS platform underscores Agilent's ability to anticipate and meet evolving customer needs, driving long-term growth.
What we're watching
- Operational Efficiency
- How the Ignite Operating System will continue to drive margin expansion and operational execution.
- Innovation Pipeline
- Whether Agilent can sustain its innovation momentum with new product launches like the 9500 ICP-MS platform.
- Market Demand
- The pace at which replacement-cycle momentum will impact revenue growth across key end markets.
Related topics